Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 30/10/2019
SIETES contiene 92829 citas

 
 
 1 a 20 de 173 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Reeve E, Low L-F, Hilmer SN. Attitudes of older adults and caregivers in Australia toward deprescribing. J Am Geriatr Soc 2019;67:junio. [Ref.ID 103159]
2. Cita con resumen
Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National survey on drug use and health. Ann Intern Med 2017;167:293-301. [Ref.ID 102021]
3. Cita con resumen
de Vries ST, van der Sar MJM, Cupelli A, Baldelli I, Coleman AM, Montero D, Sipic I, Andric A, Wennberg A, Ahlqvist-Rastad J, Denig P, Mol PGM, On behalf of SCOPE Work Package 6. Communication on safety of medicines in Europe: current practices and general practitioners’ awareness and preferences. Drug Saf 2017;40:729-42. [Ref.ID 101983]
4. Cita con resumen
Hua X, Carvalho N, Tew M, Huang ES, Herman WH, Clarke P. Expenditures and prices of antihyperglycemic medications in the United States: 2002-2013. JAMA 2016;315:1400-2. [Ref.ID 100201]
5.Tiene citas relacionadas Cita con resumen
Steinman MA. Polypharmacy—Time to get beyond numbers. JAMA Intern Med 2016;176:482-3. [Ref.ID 100069]
6.Tiene citas relacionadas Cita con resumen
Qato DM, Wilder J, Schumm LP, Gillet V, Alexander C. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med 2016;176:473-82. [Ref.ID 100068]
7. Cita con resumen
Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiology, Biomarkers, & Prevention 2015;24:1673-9. [Ref.ID 99571]
8.Enlace a cita original Cita con resumen
Puig Soler R, Perramon Colet R, Yahni CZ, Garcia Puig AM. Establecimiento de los conocimientos, actitudes y opiniones de la población sobre el uso racional de medicamentos. Aten Primaria 2015;47:446-55. [Ref.ID 98848]
9. Cita con resumen
10. Cita con resumen
Gunderson EW. Synthetic cannabinoids: a new frontier of designer drugs. Ann Intern Med 2013;159:563-4. [Ref.ID 96386]
11.
Hull SC, Colloca L, Avins A, Gordon NP, Somkin CP, Kaptchuk TJ, Miller FG. Patients' attitudes about the use of placebo treatments: telephone survey. BMJ 2013;347:15. [Ref.ID 96122]
12. Cita con resumen
Adler JN, Colbert JA. Medicinal use of marijuana - Polling results. N Engl J Med 2013;368:e30. [Ref.ID 95553]
13. Cita con resumen
Garcés Redondo G, Colán Colán C, Sánchez Oropesa A, Gómez Suanes G, Canchig Pilicita FE, López de Castro F. Opinión sobre la visita médica de los médicos de atención primaria de Toledo . Revista Clínica de Medicina de Familia 2010;3:5-9. [Ref.ID 95295]
14. Cita con resumen
Mena G, Llupià A, Sequera VG, Aldea M. Formación sanitaria especializada: preferencias y percepciones de los estudiantes de medicina. Med Clin (Barc) 2013;140:135-8. [Ref.ID 94905]
15.Tiene citas relacionadas Cita con resumen
Kale MS, Bishop TF, Federman AD, Keyhani S. Trends in the overuse of ambulatory health care services in the United States. JAMA Intern Med 2013;173:142-8. [Ref.ID 94819]
16.Tiene citas relacionadas Cita con resumen
Katz MH, Grady D, Redberg RF. Undertreatment improves, but overtreatment does not. JAMA Intern Med 2013;173:93. [Ref.ID 94815]
17. Cita con resumen
Anónimo. Vital signs: awareness and treatment of uncontrolled hypertension among adults - United States, 2003-2010. Morbidity and Mortality Weekly Report 2012;61:703-9. [Ref.ID 94314]
18.Enlace a cita original Cita con resumen
Hudson B, Zarifeh A, Young L, Wells JE. Patients' expectations of screening and preventive treatments. Ann Fam Med 2012;10:495-502. [Ref.ID 93236]
19.Enlace a cita original
Aronson JK. What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists. Br J Clin Pharmacol 2012;73:161-9. [Ref.ID 92422]
20.Enlace a cita original Cita con resumen
Anderson C, Krska J, Murphy E, Avery A, on behalf of the Yellow Card Study Collaboration. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol 2011;72:806-22. [Ref.ID 91788]
Seleccionar todas
 
 1 a 20 de 173 siguiente >>